Molecular Switches As Therapeutic Targets, Drug Development, Drug Delivery Mechanism & Application By Indications Insight 2025
Please note: extra shipping charges are applied when purchasing Hard Copy License depending on the location.
Molecular Switches As Therapeutic Targets, Drug Development, Drug Delivery Mechanism & Application By Indications Insight 2025 Research Insights:
In the pharmaceutical sector, molecular switches have revolutionized drug delivery by enabling precise spatiotemporal control over the release of active pharmaceutical ingredients. One of the most widely explored triggers is pH, as pathological conditions like cancer and inflammation often create acidic microenvironments. pH-sensitive molecular switches are employed in nanoparticle-based drug carriers, which remain stable under normal physiological conditions but disassemble in acidic environments to release their payload. For example, the FPBC@SN nanoparticle system integrates a pH-sensitive molecular switch to target acidic cytoplasm in breast cancer cells. This system releases both sorafenib, which induces ferroptosis, and an IDO inhibitor to enhance tumor immunity. By leveraging such switches, these systems reduce off-target effects and enhance the therapeutic index, addressing key challenges in oncology.
Molecular Switches As Therapeutic Targets, Drug Development, Drug Delivery Mechanism & Application By Indications Insight 2025 Research Insights:
- Top 20 Drugs Sales Targeting Molecular Switches: 2022 – 2024
- Molecular Switches Significance In Regenerative Medicine & Nanomedicine
- Molecular Switches Significance In Drug Delivery & Release
- Molecular Switches Significance As Therapeutic Targets
- Molecular Switches In Cancer Therapeutics: Breast Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Gastric Cancer
- Molecular Switches In Neurological Disorder: Parkinson’s Disease, Alzheimer’s Disease, Multiple Sclerosis
- Molecular Switches In Autoimmune & Inflammatory Disorder: Diabetes, Arthritis, Lupus, Psoriasis
In the pharmaceutical sector, molecular switches have revolutionized drug delivery by enabling precise spatiotemporal control over the release of active pharmaceutical ingredients. One of the most widely explored triggers is pH, as pathological conditions like cancer and inflammation often create acidic microenvironments. pH-sensitive molecular switches are employed in nanoparticle-based drug carriers, which remain stable under normal physiological conditions but disassemble in acidic environments to release their payload. For example, the FPBC@SN nanoparticle system integrates a pH-sensitive molecular switch to target acidic cytoplasm in breast cancer cells. This system releases both sorafenib, which induces ferroptosis, and an IDO inhibitor to enhance tumor immunity. By leveraging such switches, these systems reduce off-target effects and enhance the therapeutic index, addressing key challenges in oncology.
1. INTRODUCTION TO MOLECULAR SWITCHES
1.1 Overview
1.2 History & Emergence In Medicine
2. MOLECULAR SWITCHES CLINICAL SIGNIFICANCE IN MEDICINE
3. MOLECULAR SWITCHES SIGNIFICANCE IN DRUG DELIVERY & RELEASE
3.1 Overview
3.2 Ongoing Research & Developments
4. MOLECULAR SWITCHES SIGNIFICANCE AS THERAPEUTIC TARGETS
5. MOLECULAR SWITCHES - BROAD CLASSIFICATION
6. MOLECULAR SWITCHES BY CANCER INDICATION
6.1 Breast Cancer
6.2 Prostate Cancer
6.3 Colorectal cancer
6.4 Lung Cancer
6.5 Gastric Cancer
7. MOLECULAR SWITCHES BY NEUROLOGICAL DISORDER
7.1 Parkinson’s Disease
7.2 Alzheimer’s Disease
7.3 Multiple Sclerosis
8. MOLECULAR SWITCHES BY INFECTIOUS DISEASE
8.1 Viral Infection
8.2 Bacterial Infection
9. MOLECULAR SWITCHES BY AUTOIMMUNE & INFLAMMATORY DISORDER
9.1 Diabetes
9.2 Arthritis
9.3 Lupus
9.4 Psoriasis
10. MOLECULAR SWITCHES BY CARDIOVASCULAR DISEASE
10.1 Myocardial Infarction (Heart Attack)
10.2 Others
11. MOLECULAR SWITCHES SIGNIFICANCE IN REGENERATIVE MEDICINE
12. SALES INSIGHT OF KEY DRUGS TARGETING MOLECULAR SWITCHES
13. MOLECULAR SWITCHES IN DRUG FORMULATION
13.1 Smart Drug Formulations & Molecular Switches
13.2 Biomaterial Based Drug Delivery Systems
13.3 Self Regulating Drug Systems
14. CURRENT TRENDS & EMERGING TECHNOLOGIES
14.1 Molecular Switches In Nanomedicine
14.2 Innovations In Responsive Drug Systems
14.3 Integration With Artificial Intelligence & Machine Learning
15. FUTURE PERSPECTIVES & DIRECTIONS
15.1 Advancements In Molecular Switch Technology
15.2 The Future Of Personalized Medicine With Molecular Switches
15.3 Potential Impact On Drug Discovery & Therapeutics
Figure 1-1: Molecular Switches - Introduction
Figure 1-2: Molecular Switches – Emergence & Evolution
Figure 3-1: Molecular Switches In Drug Delivery & Release
Figure 3-2: Drug Delivery Systems With Molecular Switches
Figure 3-3: Peptide-Based Drug Delivery System
Figure 3-4: Switchable Molecular Tweezers
Figure 3-5: Rotaxane-Based Drug Delivery System
Figure 3-6: Enzyme-Activatable Drug Delivery System
Figure 3-7: Light-Responsive Drug Delivery Systems
Figure 3-8: Photo-Responsive Drug Delivery Using Spiropyran
Figure 3-9: Photopharmacological Approach For Neuropathic Pain
Figure 3-10: Insulin Prodrug Activation
Figure 6-1: AR Activation & Its Dual Role In Tumor Growth
Figure 6-2: PRL-3 Activation & AMPI-109’s Impact On TNBC
Figure 6-3: Molecular Switch in Prostate Cancer
Figure 7-1: PINK1-Parkin Molecular Switch In Parkinson’s Disease
Figure 8-1: Molecular Switches In Viral infections
Figure 11 1: Molecular Switches In Regenerative Medicine
Figure 13-1: Smart Drug Delivery With Molecular Switches
Figure 13-2: Biomaterial Based Drug Delivery Systems With Molecular Switches
Figure 13-3: Self-regulating Drug Systems With Molecular Switches
Figure 14-1: Molecular Switches In Nanomedicine
Figure 14-2: Molecular switches In Responsive Drug Systems
Figure 14-3: Integration Of Molecular Switches With Artificial Intelligence & Machine Learning
Table 1-1: Traditional v/s Molecular Switch Enabled Drug Delivery
Table 4-1: Examples Of Approved Drugs Targeting Molecular Switches
Table 5-1: Molecular Switches - Broad Classification
Table 12-1: Top 20 Drugs Targeting Molecular Switches (US$ Billion), 2022-2024
1.1 Overview
1.2 History & Emergence In Medicine
2. MOLECULAR SWITCHES CLINICAL SIGNIFICANCE IN MEDICINE
3. MOLECULAR SWITCHES SIGNIFICANCE IN DRUG DELIVERY & RELEASE
3.1 Overview
3.2 Ongoing Research & Developments
4. MOLECULAR SWITCHES SIGNIFICANCE AS THERAPEUTIC TARGETS
5. MOLECULAR SWITCHES - BROAD CLASSIFICATION
6. MOLECULAR SWITCHES BY CANCER INDICATION
6.1 Breast Cancer
6.2 Prostate Cancer
6.3 Colorectal cancer
6.4 Lung Cancer
6.5 Gastric Cancer
7. MOLECULAR SWITCHES BY NEUROLOGICAL DISORDER
7.1 Parkinson’s Disease
7.2 Alzheimer’s Disease
7.3 Multiple Sclerosis
8. MOLECULAR SWITCHES BY INFECTIOUS DISEASE
8.1 Viral Infection
8.2 Bacterial Infection
9. MOLECULAR SWITCHES BY AUTOIMMUNE & INFLAMMATORY DISORDER
9.1 Diabetes
9.2 Arthritis
9.3 Lupus
9.4 Psoriasis
10. MOLECULAR SWITCHES BY CARDIOVASCULAR DISEASE
10.1 Myocardial Infarction (Heart Attack)
10.2 Others
11. MOLECULAR SWITCHES SIGNIFICANCE IN REGENERATIVE MEDICINE
12. SALES INSIGHT OF KEY DRUGS TARGETING MOLECULAR SWITCHES
13. MOLECULAR SWITCHES IN DRUG FORMULATION
13.1 Smart Drug Formulations & Molecular Switches
13.2 Biomaterial Based Drug Delivery Systems
13.3 Self Regulating Drug Systems
14. CURRENT TRENDS & EMERGING TECHNOLOGIES
14.1 Molecular Switches In Nanomedicine
14.2 Innovations In Responsive Drug Systems
14.3 Integration With Artificial Intelligence & Machine Learning
15. FUTURE PERSPECTIVES & DIRECTIONS
15.1 Advancements In Molecular Switch Technology
15.2 The Future Of Personalized Medicine With Molecular Switches
15.3 Potential Impact On Drug Discovery & Therapeutics
Figure 1-1: Molecular Switches - Introduction
Figure 1-2: Molecular Switches – Emergence & Evolution
Figure 3-1: Molecular Switches In Drug Delivery & Release
Figure 3-2: Drug Delivery Systems With Molecular Switches
Figure 3-3: Peptide-Based Drug Delivery System
Figure 3-4: Switchable Molecular Tweezers
Figure 3-5: Rotaxane-Based Drug Delivery System
Figure 3-6: Enzyme-Activatable Drug Delivery System
Figure 3-7: Light-Responsive Drug Delivery Systems
Figure 3-8: Photo-Responsive Drug Delivery Using Spiropyran
Figure 3-9: Photopharmacological Approach For Neuropathic Pain
Figure 3-10: Insulin Prodrug Activation
Figure 6-1: AR Activation & Its Dual Role In Tumor Growth
Figure 6-2: PRL-3 Activation & AMPI-109’s Impact On TNBC
Figure 6-3: Molecular Switch in Prostate Cancer
Figure 7-1: PINK1-Parkin Molecular Switch In Parkinson’s Disease
Figure 8-1: Molecular Switches In Viral infections
Figure 11 1: Molecular Switches In Regenerative Medicine
Figure 13-1: Smart Drug Delivery With Molecular Switches
Figure 13-2: Biomaterial Based Drug Delivery Systems With Molecular Switches
Figure 13-3: Self-regulating Drug Systems With Molecular Switches
Figure 14-1: Molecular Switches In Nanomedicine
Figure 14-2: Molecular switches In Responsive Drug Systems
Figure 14-3: Integration Of Molecular Switches With Artificial Intelligence & Machine Learning
Table 1-1: Traditional v/s Molecular Switch Enabled Drug Delivery
Table 4-1: Examples Of Approved Drugs Targeting Molecular Switches
Table 5-1: Molecular Switches - Broad Classification
Table 12-1: Top 20 Drugs Targeting Molecular Switches (US$ Billion), 2022-2024
